Our thought leaders in Cell and Gene Therapy will play an active role in debates on the key challenges and latest developments in the industry. Don't miss your chance to meet our experts and discuss what matters to you.

Securing sufficient manufacturing capacity for a commercializing sector – what are the most viable short- and long-term solutions?

Dr. Thomas Fellner, Head of Cell Therapy
2:05pm - 3:30pm on Day 2 – Tuesday, January 23rd 2018, Cell-based therapy track

How are CMO consolidation trends and business/collaboration models set to evolve (eg. the ‘one-stop shop’)?

  • What will be the impact for cell & gene therapy developers? On cost of goods?
  • When is/isn’t the right time to approach a CMO?


How to truly enable decentralized manufacturing at commercial scale?

Dr. Nina Bauer, Associate Director of Autologous Cell Therapy Commercial Development
11:20am - 1:00pm on Day 4 – Thursday, January 25rd 2018, Cell-based therapy track

How comfortable are industry, regulators, clinicians and healthcare providers alike with moving cell & gene therapy bioprocessing closer to patients? Where do their chief remaining concerns lie?

  • What would increasing point of care manufacturing mean for GMP oversight/levels, moving forward?
  • How to (re-)design workflows around raw material acquisition, logistics and quality/release testing in the decentralized scenario?
  • How to deal with the thorny issue of demonstrating comparability across multiple clinical sites?
  • How far away is the fully sealed, ‘GMP in a box’ bedside solution in reality?
  • Who will take ownership of the various components of tomorrow’s point of care manufacturing and supply chain model(s) for cell & gene therapy products?


How to address viral and non-viral vector manufacturing capacity/supply shortfalls before they reach crisis point?

Dr. Ryan Scanlon, Head of Batch-Viral Gene Therapy
11:20am - 12:35pm on Day 3 – Wednesday, January 24th 2018, Gene therapy track

Defining the scale of the challenge and the strategic solutions available today and in the near future for...

  • AAV
  • Lentiviral
  • Retroviral
  • Plasmid DNA


Use the form below to organize a meeting with us during or around the Cell & Gene Therapy World 2018 congress. Together, we can reach the next milestone in cell and gene therapy.